카페검색 본문
카페글 본문
-
영한통역 연설 "Generic Drug : Gift of Innovation" 2009.04.08해당카페글 미리보기
is produced by generic companies. But no pharmaceutical company can afford to test new indications for a drug that is already generic — or will be soon, regardless of whatever promising signals may be arising from late stage post...
-
수정1, 수정2, EN-한글, 약물 부작용 소송 할수 있습니다. 2024.10.03해당카페글 미리보기
Court's decision in Mutual Pharmaceutical Company vs. Karen Bartlett in 2013 limited consumers' ability to sue generic drug manufacturers. 제약 회사를 고소하는 것을 고려하고 있다면, 경험이 풍부한 제조물 책임 변호사와 상담해야 합니다. If...
-
GENERIC NAME: CLOBETASOL 2023.10.04해당카페글 미리보기
GENERIC NAME: CLOBETASOL This medication is used to treat a variety of skin conditions (such as eczema, psoriasis, dermatitis, allergies, rash). Clobetasol reduces the swelling, itching, and redness that can occur in these types of...
-
이버멕틴의 신경 보호 특성은 EMF, 백신으로 인한 손상으로부터 보호할 수 있습니다. 2024.07.18해당카페글 미리보기
could protect against damage from EMFs, vaccines – NaturalNews.com Science has uncovered more uses for the generic antiparasitic drug ivermectin, which was the subject of great controversy during the Wuhan coronavirus (COVID-19...
-
For First Time, F.D.A. Panel Approves Generic Copy of Costly Biologic Drug-NYT1/7 :미국 식약청(FDA) 복제약(Bio similas)생산 최초 승인 배경과 영향 전망 2015.01.08해당카페글 미리보기
Angeles. A version of this article appears in print on January 8, 2015, on page B3 of the New York edition with the headline: For First Time, F.D.A. Panel Approves Generic Copy of Costly Biologic Drug. Order Reprints|Today's Paper|Subscribe
